Frontlight ResearchEarly access
Trial site
Thomas Jefferson University, Sidney Kimmel Comprehensive Cancer Center
- 3running trials
The trials here
What the 3 trials at this site are about, from their registry records.
- Conditions
- Colorectal cancer2 trials
- Endometrial cancer1 trial
- Gastric and oesophageal cancer1 trial
- Glioblastoma1 trial
- Ovarian cancer1 trial
- Prostate cancer1 trial
- Phase
- Phase 22 trials
- Phase 1/21 trial
- Status
- Recruiting3 trials
- Lead sponsor
- 858 Therapeutics, Inc.1 trial
- Black Diamond Therapeutics, Inc.1 trial
- Criterium, Inc.1 trial
Running trials
Recruiting
Recruiting
Recruiting
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Colorectal cancer2 recruiting
- Endometrial cancer1 recruiting
- Gastric and oesophageal cancer1 recruiting
- Glioblastoma1 recruiting
- Ovarian cancer1 recruiting
- Prostate cancer1 recruiting
Site data: ClinicalTrials.govUpdated 12 Nov 2026